291 related articles for article (PubMed ID: 12220374)
1. Myotonic dystrophy type 2.
Finsterer J
Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic heterogeneity in myotonic dystrophies.
Meola G
Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
[TBL] [Abstract][Full Text] [Related]
4. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
5. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular aspects of the myotonic dystrophies: a review.
Machuca-Tzili L; Brook D; Hilton-Jones D
Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
[TBL] [Abstract][Full Text] [Related]
7. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2).
Day JW; Roelofs R; Leroy B; Pech I; Benzow K; Ranum LP
Neuromuscul Disord; 1999 Jan; 9(1):19-27. PubMed ID: 10063831
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variability and molecular genetics in proximal myotonic myopathy.
Papadimas GK; Kekou K; Papadopoulos C; Kararizou E; Kanavakis E; Manta P
Muscle Nerve; 2015 May; 51(5):686-91. PubMed ID: 25186227
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
13. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
14. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
[TBL] [Abstract][Full Text] [Related]
15. [Myotonic dystrophy - a new insight into a well-known disease].
Lusakowska A; Sułek-Piatkowska A
Neurol Neurochir Pol; 2010; 44(3):264-76. PubMed ID: 20625963
[TBL] [Abstract][Full Text] [Related]
16. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
17. The expanding clinical and genetic spectrum of the myotonic dystrophies.
Ricker K
Acta Neurol Belg; 2000 Sep; 100(3):151-5. PubMed ID: 11098287
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
20. [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].
Schneider C; Reiners K; Toyka KV
Nervenarzt; 2001 Aug; 72(8):618-24. PubMed ID: 11519202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
